Literature DB >> 333852

Comparison of the analgesic effects of intravenous nalbuphine and pentazocine in patients with postoperative pain.

T Tammisto, I Tigerstedt.   

Abstract

One hundred patients, who were in pain during the immediate postoperative period after upper abdominal operations, were included in this double-blind, between-patient, two-dose study. During N2O-O2-halothane-relaxant anaesthesia no analgesics were given. The patients received 0.07 mg/kg or 0.14 mg/kg of nalbuphine or 0.3 mg/kg or 0.6 mg/kg of pentazocine by intravenous injection. Pain and side effects were assessed for 4 h after administration of the test drug, or until the pain returned to the pre-injection level, when a conventional analgesic was given. The onset of pain relief was similar and the peak effect occurred about half an hour after the injection after both drugs. On a milligram basis, nalbuphine seemed to be about three times as potent as pentazocine. The duration of action seemed to be slightly longer after nalbuphine, but 2 1/2 hrs. after the injection the pain had returned to preinjection level in 2/3 of the patients, even after the higher doses of both drugs. Except for sleepiness, there were few side effects and they were similar after both drugs. No psychotomimetic effects were observed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 333852     DOI: 10.1111/j.1399-6576.1977.tb01237.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  10 in total

1.  The pharmacokinetics of intravenous, intramuscular, and subcutaneous nalbuphine in healthy subjects.

Authors:  M W Lo; F H Lee; W L Schary; C C Whitney
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 2.  Clinical pharmacokinetics of narcotic agonist-antagonist drugs.

Authors:  R E Bullingham; H J McQuay; R A Moore
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

3.  A major psychotomimetic complication of multidrug intravenous sedation.

Authors:  J T Jastak; F J Marshall
Journal:  Anesth Prog       Date:  1984 Sep-Oct

4.  Nalbuphine and pentazocine in an opioid-benzodiazepine sedative technique: a double-blind comparison.

Authors:  J L Graham; W McCaughey; P F Bell
Journal:  Ann R Coll Surg Engl       Date:  1988-07       Impact factor: 1.891

Review 5.  Opioid agonist-antagonist drugs in acute and chronic pain states.

Authors:  P J Hoskin; G W Hanks
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

6.  Patient-controlled analgesia with nalbuphine, a new narcotic agonist-antagonist, for the treatment of postoperative pain.

Authors:  K A Lehmann; B Tenbuhs
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Effect of nalbuphine on intrabiliary pressure in the early postoperative period.

Authors:  E Vatashsky; Y Haskel
Journal:  Can Anaesth Soc J       Date:  1986-07

8.  Experience with nalbuphine, a new opioid analgesic, in acute myocardial infarction.

Authors:  R A Greenbaum; G Kaye; P D Mason
Journal:  J R Soc Med       Date:  1987-07       Impact factor: 5.344

Review 9.  Nalbuphine. A preliminary review of its pharmacological properties and therapeutic efficacy.

Authors:  J K Errick; R C Heel
Journal:  Drugs       Date:  1983-09       Impact factor: 9.546

10.  Comparative Study of Efficacy of Preoperative Nalbuphine Hydrochloride and Pentazocine Lactate on Hemodynamic Response to Tracheal Intubation and Postoperative Analgesia.

Authors:  Namrata Natraj Sadafule; Seema Shripad Karhade
Journal:  Anesth Essays Res       Date:  2018 Jan-Mar
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.